Table 1.

Clinical Trials of Epigenetic Therapies in AML from ClinicalTrials.gov, accessed May 2014

Clinical Trials of Epigenetic Therapies in AML from ClinicalTrials.gov, accessed May 2014

*DNMTi=DNA Methyltransferase Inhibitors.

**HDAC=Histone Deacetylase.

***HMT=Histone Methyltransferase.

****BET=Bromo and Extra Terminal.

ß: A=azacitidine, B=bortezomib, BR=brentuximab, C=cytarabine, CL=clofarabine, D=decitabine, DA=daunorubicin, E=etoposide, EN=entinostat, ER=erismodegib, GO=gemtuzumab ozogamicin, HI=hedgehog inhibitor, I=idarubicin, L=lenalidomide, M=mitoxantrone, MD=midostaurin, P=panobinostat, PR=pracinostat, R=rigosertib, RA=rapamycin, RBV=ribavirin, S= selinexor, SI=sirolimus, SO=sorafenib, T=temozolomide V=vosaroxin, VA= valproic acid, VO=volasertib, VOR=vorinostat.

Close Modal

or Create an Account

Close Modal
Close Modal